Viral load assay sensitivity and low level viremia in HAART treated HIV patients
- 30 April 2010
- journal article
- research article
- Published by Elsevier BV in Journal of Clinical Virology
- Vol. 47 (4), 335-339
- https://doi.org/10.1016/j.jcv.2010.01.008
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Increased Reporting of Detectable Plasma HIV-1 RNA Levels at the Critical Threshold of 50 Copies per Milliliter With the Taqman Assay in Comparison to the Amplicor AssayJAIDS Journal of Acquired Immune Deficiency Syndromes, 2009
- Detection of HIV Type 1 Load by the Roche Cobas TaqMan Assay in Patients with Viral Loads Previously Undetectable by the Roche Cobas Amplicor MonitorClinical Infectious Diseases, 2009
- Increased Detectability of Plasma HIV‐1 RNA after Introduction of a New Assay and Altered Specimen‐Processing ProceduresClinical Infectious Diseases, 2008
- The Significance of Low-Level Plasma HIV Viral Load on COBAS TaqMan® HIV-1 Assays for Patients with Undetectable Plasma Viral Load on COBAS Amplicor® Monitor Version 1.5HIV Research & Clinical Practice, 2008
- Comparative Evaluation of the Automated Roche TaqMan Real-Time Quantitative Human Immunodeficiency Virus Type 1 RNA PCR Assay and the Roche AMPLICOR Version 1.5 Conventional PCR AssayJournal of Clinical Microbiology, 2007
- Intermittent HIV-1 Viremia (Blips) and Drug Resistance in Patients Receiving HAARTJAMA, 2005
- Prevalence and Predictive Value of Intermittent Viremia With Combination HIV TherapyJAMA, 2001
- Residual HIV-1 RNA in Blood Plasma of Patients Taking Suppressive Highly Active Antiretroviral TherapyJAMA, 1999
- Persistence of HIV-1 Transcription in Peripheral-Blood Mononuclear Cells in Patients Receiving Potent Antiretroviral TherapyNew England Journal of Medicine, 1999